Doctor drawing man's blood sample in clinic, closeup  AdobeStock_1937412501

Rethinking Early Detection: Type 1 Diabetes in Young Adults

Diabetes IDF Environmental Health EPI

A population-based cohort study provides new data on the prevalence of early-stage type 1 diabetes in young adults, addressing a gap in epidemiological research. Using samples from the LISA and GINIplus cohorts and methodologies established in the Fr1da study, researchers from the Institute of Diabetes Research and the Institute of Epidemiology at Helmholtz Munich demonstrate the potential of extending early detection strategies into adulthood. The findings are presented in a new Correspondence published in The Lancet Diabetes & Endocrinology.

Investigating Presymptomatic Type 1 Diabetes Beyond Childhood

Type 1 diabetes is a chronic autoimmune disease characterized by the immune-mediated destruction of insulin-producing beta cells. Although traditionally regarded as a childhood-onset condition, it is now increasingly recognized that type 1 diabetes can also manifest during adolescence and adulthood. Helmholtz Munich researchers have investigated the prevalence of early-stage type 1 diabetes in young adults, addressing an underexplored phase of the disease. The study was conducted through close collaboration between the Institute of Epidemiology (EPI) and the Institute of Diabetes Research (IDF), combining expertise in population-based epidemiology and the pathophysiology of diabetes.

The analysis included 1,377 participants from the long-running LISA and GINIplus birth cohorts, which follow individuals prospectively from birth into young adulthood, with assessments conducted up to 25 years of age. Blood samples were screened for islet autoantibodies using the methodology established in the Fr1da Study, including confirmatory testing to ensure high analytical specificity. 

Islet Autoantibodies Can Develop During Adolescence and Early Adulthood

The results show that approximately 1.2 percent of previously undiagnosed young adults tested positive for islet autoantibodies, including 0.2 percent of participants who met the criteria for early-stage type 1 diabetes – prevalence rates comparable to those observed in children – and an additional 1.0 percent who had a single autoantibody. Longitudinal analyses indicated that, while the majority  of the autoantibody-positive individuals had these markers by age 15 years, new development of islet autoantibodies occurred after this age. This underscores that early immunological signs of type 1 diabetes can emerge during adolescence and young adulthood.

The findings provide new evidence that early-stage type 1 diabetes occurs in the general adult population, highlighting the potential value of extending screening strategies currently focusing on children to include young adults, particularly in those who have not been previously tested in adolescence.

Original Publication

Standl et al., Prevalence of early-stage type 1 diabetes in young adults: a population-based cohort study. The Lancet Diabetes & Endocrinology. DOI: 10.1016/ S2213-8587(26)00034-3

[Translate to German:]
Univ.-Prof. Dr. med. Anette-Gabriele Ziegler

Institute Director, Chair of Diabetes and Gestational Diabetes, Klinikum rechts der Isar and Technical University of Munich, Director of the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD)

View profile
Portrait Peter Achenbach
Prof. Dr. med. Peter Achenbach

Deputy Director, Lead Scientist Research Area: Study Center for Childhood Diabetes

View profile
Porträt Marie Standl; EPI
Dr. Marie Standl

Head of Research Group 'Allergic Disease Epidemiology', Head (ad interim) of Research Group 'Lung Epidemiology', Statistician

View profile

Related news

Blood Screening for Type 1 Diabetes

New Research Findings, Diabetes, IDF,

100,000 Participants Screened for Early-Stage Type 1 Diabetes in the EDENT1FI Project

EDENT1FI (“European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception”), a research project led by Prof. Anette-Gabriele Ziegler from Helmholtz Munich and Prof. Chantal Mathieu from the KU Leuven, has reached an…

Panoramic teamwork business join hand together concept, Business team standing hands together, Volunteer charity work. People joining for cooperation success business.

Transfer, Diabetes, IDR, IDF,

Our Partnerships for a World Without Diabetes

Researchers at Helmholtz Munich are working toward a world without diabetes. They are not doing so alone, but with a network of organizations, hospitals, and pharmaceutical companies. Their goal is to use experts’ knowledge to create something new:…

Classmates cheering up each other before game.

Diabetes, IDF,

Early Detection Tests for a World Without Type 1 Diabetes

At Helmholtz Munich, scientists are working to ensure that no child will have to suffer from the autoimmune disease type 1 diabetes in the future.